Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Timothy C. Thompson, Sanghee Park et al.|Science Signaling|2017Cited by 307
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Timothy C. Thompson, Theodoros Karantanos et al.|Cell Reports|2017Cited by 107